We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The CMA has imposed over £100 million in fines after Advanz inflated the price of thyroid tablets, causing the NHS and patients to lose out.
Number and cost of tablet computers.
The CMA has imposed fines totalling over £260 million for competition law breaches in relation to the supply of hydrocortisone tablets.
The £2.5 million Digital Lifeline Fund will provide devices, data and digital support to people with learning disabilities who can't afford to get online.
The CMA has provisionally found that Pfizer and Flynn abused their dominant positions to overcharge the NHS for vital anti-epilepsy drugs, after reassessing the case.
Number and cost of tablet computers issued 2010 to 2015.
The CMA has secured the disqualification of a director whose company admitted it breached competition law.
Schools should register their initial interest by 6 May 2016 to buy tablet devices using sector collective buying power.
The CMA has issued decisions imposing fines on suppliers of nortriptyline tablets for breaching competition law.
Schools and councils have received over 560,000 devices this year to support remote education
The CMA has fined firms over £35 million for an illegal arrangement in the supply of important NHS prescription anti-nausea tablets.
Lupin Healthcare (UK) Limited has informed us that the affected batches of Simvastatin tablets have been packaged with a version of patient information leaflet that does not include the most up to date safety information.
Batch Number 1K10121 has been found to potentially have the wrong amount of active ingredients
The CMA is investigating alleged excessive and unfair prices with respect to hydrocortisone tablets under Chapter II CA98/ Article 102 TFEU.
Nuromol, a medicine that contains 200mg of ibuprofen and 500mg of paracetamol per tablet will become available without the need to visit a pharmacy
After reassessing part of the case, the CMA has found that Pfizer and Flynn abused their dominant positions to overcharge the NHS for a life-saving epilepsy drug.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).